caa a22 4500 469033444 CHVBK 20180323132750.0 cr unu---uuuuu 170328e19920501xx s 000 0 eng 10.1007/BF00661090 doi (NATIONALLICENCE)springer-10.1007/BF00661090 Nomenclature for factors of the HLA system, 1991 [Elektronische Daten] [J. Bodmer, E. Albert, W. Bodmer, B. Dupont, H. Erlich, B. March, S. Marsh, W. Mayr, P. Parham, T. Sasasuki, G. Schreuder, J. Strominger, A. Svejgaard, P. Terasaki] Springer-Verlag, 1992 Bodmer J. Imperial Cancer Research Fund, London, UK (Rapporteur) aut Albert E. Policlinic for Children, University of Munich, FRG (Chairman) aut Bodmer W. Sloan-Kettering Institute for Cancer Research, New York, NY, USA aut Dupont B. Cetus Corporation, Emeryville, CA, USA aut Erlich H. University of Geneva, Geneva, Switzerland aut March B. Imperial Cancer Research Fund, London, UK aut Marsh S. Sloan-Kettering Institute for Cancer Research, New York, NY, USA aut Mayr W. Rheinisch-Westfälische Technische Hochschule, Aachen, FRG aut Parham P. Stanford University School of Medicine, Stanford, CA, USA aut Sasasuki T. Kyushu University, Fukuoka, Japan aut Schreuder G. University Hospital, Leiden, The Netherlands aut Strominger J. Hardvard University, Cambridge, MA, USA aut Svejgaard A. State University Hospital, Copenhagen, Denmark aut Terasaki P. University of California, Los Angeles, CA, USA aut Immunogenetics Springer-Verlag 36/3(1992-05-01), 135-148 0093-7711 36:3<135 1992 36 251 https://doi.org/10.1007/BF00661090 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF00661090 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Bodmer J. Imperial Cancer Research Fund, London, UK (Rapporteur) aut NATIONALLICENCE 700 1- Albert E. Policlinic for Children, University of Munich, FRG (Chairman) aut NATIONALLICENCE 700 1- Bodmer W. Sloan-Kettering Institute for Cancer Research, New York, NY, USA aut NATIONALLICENCE 700 1- Dupont B. Cetus Corporation, Emeryville, CA, USA aut NATIONALLICENCE 700 1- Erlich H. University of Geneva, Geneva, Switzerland aut NATIONALLICENCE 700 1- March B. Imperial Cancer Research Fund, London, UK aut NATIONALLICENCE 700 1- Marsh S. Sloan-Kettering Institute for Cancer Research, New York, NY, USA aut NATIONALLICENCE 700 1- Mayr W. Rheinisch-Westfälische Technische Hochschule, Aachen, FRG aut NATIONALLICENCE 700 1- Parham P. Stanford University School of Medicine, Stanford, CA, USA aut NATIONALLICENCE 700 1- Sasasuki T. Kyushu University, Fukuoka, Japan aut NATIONALLICENCE 700 1- Schreuder G. University Hospital, Leiden, The Netherlands aut NATIONALLICENCE 700 1- Strominger J. Hardvard University, Cambridge, MA, USA aut NATIONALLICENCE 700 1- Svejgaard A. State University Hospital, Copenhagen, Denmark aut NATIONALLICENCE 700 1- Terasaki P. University of California, Los Angeles, CA, USA aut NATIONALLICENCE 773 0- Immunogenetics Springer-Verlag 36/3(1992-05-01), 135-148 0093-7711 36:3<135 1992 36 251 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer